相关实验视频
Updated: Sep 11, 2025

05:16
Sleeve Gastrectomy in Mice using Surgical Clips
Published on: November 14, 2020
6.8K
关于外科决定的ChatGPT培训:使用算法和证据进行腹外科分析
Sergi Sanchez-Cordero1, Ruth Lopez-Gonzalez1, Helena Fernandez2
1Bariatric Surgery, Moises Broggi University Hospital, Barcelona, Spain.
Obesity research & clinical practice
|August 15, 2025
概括
对减肥手术的ChatGPT建议与临床决策的一致性很低,即使在对科学文献进行AI培训之后. 人工智能工具对于自主手术选择还不够可靠.
科学领域:
- 腹部外科 腹部外科
- 人工智能在医学中的应用
- 手术决策支持系统 手术决策支持系统
背景情况:
- 腹腔外科手术 (BS) 的选择是复杂的和个性化的.
- 像ChatGPT这样的人工智能 (AI) 工具可能提供决策支持,但临床实用性尚未得到证实.
- 评估AI在优化BS技术选择中的作用至关重要.
研究的目的:
- 评估ChatGPT的减肥手术建议是否在科学文献的AI培训后得到改善.
- 将ChatGPT的建议与减肥手术中的实际临床决定进行比较.
- 确定人工智能在减肥手术决策中的临床实用性.
主要方法:
- 对283名初级减肥手术患者 (2023-2025) 的回顾性分析.
- 在412篇科学文章中,ChatGPT在培训前和培训后推的BS技术.
- 建议与实际的临床决定进行了比较,使用百分比协议和科恩公司.
主要成果:
- 最初的ChatGPT建议支持袖子胃切除术 (SG),与临床实践相一致20%.
- 在培训结束后,建议发生了转变,SG下降,SADI-S出现.
- 一致性提高到25.8%,但仍然很低,表明与临床判断的结合有限.
结论:
- ChatGPT的减肥手术建议适应培训后,但与临床决策的一致性很低.
- 人工智能显示出作为减肥手术教育工具的潜力.
- 当前的人工智能模型在减肥手术中对自主手术决策不可靠.
相关概念视频
Cancer Survival Analysis
455
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
455
Kidney Transplant II: Surgical Procedure
75
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
75

